State
73,817 recalls have nationwide distribution and so reach South Carolina. 7,153 additional recalls listed South Carolina specifically in their distribution scope.
Of the 7,153 recalls naming South Carolina we have scored against our rubric, 1,275 (18%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,170 (30%) are Severe.
Which agencies issued them
These figures cover only the 7,153 recalls whose distribution notice names South Carolina specifically. The 73,817 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Terumo is voluntarily recalling Level Sensor II Gel Pads because the expiration date format may not be recognizable to all users.
Synergy Rx is recalling Metronidazole 1% Gel and Metronidazole/Niacinamide/Azelaic Cream due to lack of assurance of sterility and CGMP deviations.
Merge Healthcare is recalling Merge Hemo software versions 6.10 through 9.40.3 because the system may incorrectly lock study tabs, potentially preventing access to data.
LeMaitre Vascular is recalling 4,673 units of Scoop Tip Cholangiogram Catheters because the latex warning symbol was not printed on the packaging.
Synergy Rx is recalling Fluocinonide 0.05% Solution due to a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling various betamethasone cream and ointment products due to a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling Enhanced Retin Anti-Wrinkle Cream due to lack of assurance of sterility and CGMP deviations.
Radiometer America Inc. is recalling ABL800 analyzers because the 'cord blood' sample type was changed to 'cord blood arterial' and 'cord blood venous.'
LeMaitre Vascular is recalling 250 units of Reddick Cholangiogram Stiffer Catheters because the latex warning symbol was not printed on the packaging.
Synergy Rx is recalling Generic VI Peel products nationwide due to a lack of assurance of sterility and CGMP deviations.
Siemens is recalling Artis Zee and Zeego fluoroscopic x-ray systems because a gap in the wireless foot switch housing could allow liquids to penetrate the interior, potentially causing the switch to fail.
Amerisource Health Services is recalling specific lots of Glipizide Extended-Release tablets because they failed to meet dissolution specifications.
LeMaitre Vascular is recalling 46 units of Reddick Scoop Tip Cholangiogram Stiffer Catheters because the latex warning symbol was missing from the packaging.
Siemens is recalling Axiom Artis fluoroscopic x-ray systems because a gap in the wireless foot switch housing could allow liquids to penetrate the interior, potentially causing the switch to fail.
Synergy Rx is recalling Hydroquinone 28% Solution because it may not be sterile. The recall covers all lots distributed nationwide.
Synergy Rx is recalling Tretinoin 0.02% in Oil Free Cream because of a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling specific glycolic acid prescription products due to a lack of assurance of sterility and CGMP deviations.
LeMaitre Vascular is recalling Reddick Scoop Tip Cholangiogram Catheters because the latex symbol was not printed on the packaging.
Radiometer America Inc. is recalling ABL90 Flex analyzers because the 'cord blood' sample type was changed to 'cord blood arterial' and 'cord blood venous.'
LeMaitre Vascular is recalling Reddick Scoop Tip Cholangiogram Catheters because the latex warning symbol was missing from the packaging.
LeMaitre Vascular is recalling 340 Reddick Cholangiogram Stiffer Catheters because the latex symbol was not printed on the packaging.
Pharmedium Services, LLC is recalling 3,879 syringes of Buffered Lidocaine because the outer packaging is incorrectly labeled as 1% instead of 0.9%.
Colgate is recalling 14,656 bottles of PreviDent 5000 toothpaste because the rear panel is incorrectly labeled with text from a different product.
G&W Laboratories is recalling specific lots of Clindamycin Phosphate Topical Solution because an expired active ingredient was used during manufacturing.
Pfizer is recalling 582,165 vials of PROTONIX IV (pantoprazole sodium) because the drug failed potency testing at the 6-month stability time point.